These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 28774232)
1. Editorial. Kasper S World J Biol Psychiatry; 2017 Sep; 18(6):409. PubMed ID: 28774232 [No Abstract] [Full Text] [Related]
2. Searching for rational anti N-methyl-D-aspartate treatment for depression. Tsai GE Arch Gen Psychiatry; 2007 Sep; 64(9):1099-100; author reply 1100-1. PubMed ID: 17768278 [No Abstract] [Full Text] [Related]
3. Ketamine Use for Suicidal Ideation in the General Hospital: Case Report and Short Review. Vulser H; Vulser C; Rieutord M; Passeron A; Lefebvre D; Baup E; Seigneurie AS; Thauvin I; Limosin F; Lemogne C J Psychiatr Pract; 2018 Jan; 24(1):56-59. PubMed ID: 29320385 [TBL] [Abstract][Full Text] [Related]
4. Administration of ketamine for unipolar and bipolar depression. Kraus C; Rabl U; Vanicek T; Carlberg L; Popovic A; Spies M; Bartova L; Gryglewski G; Papageorgiou K; Lanzenberger R; Willeit M; Winkler D; Rybakowski JK; Kasper S Int J Psychiatry Clin Pract; 2017 Mar; 21(1):2-12. PubMed ID: 28097909 [TBL] [Abstract][Full Text] [Related]
5. Successful Use of Ketamine for the Treatment of Psychotic Depression in a Teenager. Zarrinnegar P; Kothari J; Cheng K J Child Adolesc Psychopharmacol; 2019 Aug; 29(6):472-473. PubMed ID: 31161948 [No Abstract] [Full Text] [Related]
6. [Ketamine for treatment of acute depression]. Hjerrild S; Bjerre J; Pedersen RH; Videbech P Ugeskr Laeger; 2013 Sep; 175(37):2090-3. PubMed ID: 24011203 [TBL] [Abstract][Full Text] [Related]
8. Treatment-refractory depression: a case of successful treatment with intranasal ketamine 10%. Clark P Ann Clin Psychiatry; 2014 May; 26(2):145. PubMed ID: 24501735 [No Abstract] [Full Text] [Related]
9. Drugs for psychiatric disorders. Treat Guidel Med Lett; 2013 Jun; 11(130):53-64; quiz 2p following 64. PubMed ID: 23715100 [No Abstract] [Full Text] [Related]
10. Ketamine as an antidepresessant: a brief research history. Wanderer JP; Rathmell JP Anesthesiology; 2014 Jul; 121(1):A29. PubMed ID: 24936933 [No Abstract] [Full Text] [Related]
11. Time until relapse after augmentation with single-dose ketamine in treatment-resistant depression. Pérez-Esparza R; Corona T; Ruiz-García RG; Oñate-Cadena N; de la Fuente-Sandoval C; Ramírez-Bermúdez J Psychiatry Clin Neurosci; 2018 Aug; 72(8):623. PubMed ID: 29744959 [No Abstract] [Full Text] [Related]
13. Different effects of the NMDA receptor antagonists ketamine, MK-801, and memantine on postsynaptic density transcripts and their topography: role of Homer signaling, and implications for novel antipsychotic and pro-cognitive targets in psychosis. de Bartolomeis A; Sarappa C; Buonaguro EF; Marmo F; Eramo A; Tomasetti C; Iasevoli F Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():1-12. PubMed ID: 23800465 [TBL] [Abstract][Full Text] [Related]
14. Drugs and depression. Harris B Am J Nurs; 1986 Mar; 86(3):292-3. PubMed ID: 2869688 [No Abstract] [Full Text] [Related]
15. Research suggests new drug targets for depression. Pilot studies of ketamine intrigue scientists, but risks of this anesthetic limit its clinical use. Harv Ment Health Lett; 2010 Nov; 27(5):6. PubMed ID: 21218614 [No Abstract] [Full Text] [Related]
16. Olanzapine and delirium: lesson from clinical practice. Singh D; Forlano R Aust N Z J Psychiatry; 2008 May; 42(5):433-4. PubMed ID: 18499932 [No Abstract] [Full Text] [Related]